葫蘆巴（胡蘆巴） Fenugreek × 第二型糖尿病
結論：證據支持但有警示
四篇統合分析（Gong 2016、Huang 2023、Kim 2023、Hadi 2024）方向一致顯示葫蘆巴可降低 HbA1c（-0.
B 🟡 B 初步證據 附警語發布 ⚠️ medium — moderate promotional content
四篇統合分析（Gong 2016、Huang 2023、Kim 2023、Hadi 2024）方向一致顯示葫蘆巴可降低 HbA1c（-0.54% 至 -1.16%）與空腹血糖，這是葫蘆巴最強的療效主張，訊號真實存在。
但異質性極端（FBG I²=99%、HbA1c I²=75%），最大效應量來自較舊低品質試驗且疑有小研究偏差，最強的 Fenfuro RCT 為業界資助並以百分比變化誇大效果，受試族群集中於南亞、試驗規模小、多為加成式設計難以分離葫蘆巴本身效果。
方向一致支持正向評級，但品質與異質性問題使其無法評為頂層，故定為 B（中度／混合 RCT 證據）。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.56
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
74%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.565
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (5 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials
結論：Fenugreek significantly reduced FPG by WMD -20.32 mg/dL (95% CI: -26.65 to -13.99) and HbA1c by WMD -0.54% (95% CI: -0.80 to -0.28); no significant effect on fasting insulin or triglycerides.
前往 PubMed
The Effect of Fenugreek in Type 2 Diabetes and Prediabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
結論：Fenugreek significantly reduced FBG, HbA1c, and 2-hPG; improved total cholesterol, triglycerides, and HDL-C; no significant effect on HOMA-IR, LDL-C, or BMI; no hepatic/renal toxicity.
前往 PubMed
Effect of Fenugreek on Hyperglycemia: A Systematic Review and Meta-Analysis
結論：FBG reduction not significant (MD -3.70 mg/dL, 95% CI: -27.02 to 19.62, p=0.76; I²=99.37%); HbA1c significantly reduced (MD -0.88%, 95% CI: -1.49 to -0.27, p=0.004; I²=74.79%). Very high heterogeneity across FBG studies.
前往 PubMed
Enhancing glycaemic control and promoting cardiovascular health: the therapeutic potential of Trigonella foenumgraecum in diabetic patients - a systematic review and meta-analysis
結論：Fenugreek significantly reduced FBS (P<0.001), HbA1c (P<0.001), and postprandial glucose (P<0.001) in type 2 diabetic patients.
前往 PubMed
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis
結論：Fenugreek significantly reduced FBG (MD -0.84 mmol/L, 95% CI: -1.38 to -0.31, p=0.002) and HbA1c (MD -1.16%, 95% CI: -1.23 to -1.09, p<0.00001); also significantly reduced total cholesterol; no hepatic/renal toxicity.
前往 PubMed
Effect of Fenugreek Use on Fasting Blood Glucose, Glycosylated Hemoglobin, Body Mass Index, Waist Circumference, Blood Pressure and Quality of Life in Patients with Type 2 Diabetes Mellitus: A Rand…
結論：Fenugreek group showed significant reductions in FBS and HbA1c vs. placebo (P<0.001); also improved BMI, waist circumference, diastolic BP, and quality of life.
前往 PubMed
A randomized double blind placebo controlled trial to assess the safety and efficacy of a patented fenugreek (Trigonella foenum-graecum) seed extract in Type 2 diabetics
結論：Fenfuro® reduced FBG by 38%, postprandial glucose by 44%, and HbA1c by 34.7% vs. placebo; no adverse events or significant changes in safety markers.
前往 PubMed
L4a US FDA
支持
FLAVORING AGENT OR ADJUVANT 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
葫蘆巴；希臘草 / Fenugreek, Goat horn, Cow horn / Trigonella foenum-graecum L. — 草、木本植物類(2) — 種子、葉、芽(苗) — 得作為食品之單一或主要原料 來源↗
L4e WHO
支持
WHO Monographs on Selected Medicinal Plants, Volume 3 (Geneva, 2007): monograph "Semen Trigonellae Foenugraeci" (p. 338). Uses supported by clinical data — none listed. Uses described in traditional medicine/not yet proven by clinical data: orexigenic (loss of appetite); galactagogue; adjuvant in diabetes mellitus and mild hypercholesterolaemia. External use: local anti-inflammatory (minor skin… 來源↗
L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
謹慎
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
在 PTT（FITNESS/regimen/MobileComm）、Dcard、Mobile01、痞客邦等台灣社群，幾乎找不到鄉民針對「葫蘆巴（胡蘆巴）用於第二型糖尿病／降血糖」的第一手實測心得。以 site:ptt.cc / site:dcard.tw / site:mobile01.com 限定搜尋『葫蘆巴 血糖』均無命中——血糖相關討論清一色是血糖機選購、CGM、斷食控糖、糖尿病前期逆轉等主題，無人提及葫蘆巴。葫蘆巴在台灣社群的能見度極低，僅有的少量討論集中在哺乳媽媽『發奶／增加奶量』用途（如 GK 媽咪、相關媽媽社團），而非降血糖。所有與『葫蘆巴 降血糖』相關的中文頁面皆來自保健品電商與健康媒體業配內容（亞尼活力、95dan、悠活原力、primeplus、中華生醫、KingNet、元氣網），並非匿名社群實證。判定為社群無相關討論（not_addressed），不捏造心得。
💬社群實感
無共識（台灣社群幾乎無針對降血糖／第二型糖尿病的第一手實測討論；葫蘆巴在地討論多集中於哺乳發奶用途，與血糖無關）
- 醫療營養治療與減重
- 規律身體活動
- Metformin（二甲雙胍）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-type2-diabetes-INT-fenugreek-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "葫蘆巴（胡蘆巴）能改善第二型糖尿病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}